TCR2 Therapeutics Target Price Raised to $2.11 From $1.72 at Mizuho Securities
TCR2 Therapeutics Target Price Raised to $2.11 From $1.72 at Mizuho Securities
瑞穗证券将TCR2 Therapeutics的目标价格从1.72美元上调至2.11美元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册